CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 90 filers reported holding CYTOSORBENTS CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $420,000 | +677.8% | 131,655 | +912.5% | 0.06% | +700.0% |
| Q4 2021 | $54,000 | -90.8% | 13,003 | -82.9% | 0.01% | -95.2% |
| Q1 2020 | $586,000 | +134.4% | 75,869 | +16.8% | 0.15% | +406.9% |
| Q4 2019 | $250,000 | +51.5% | 64,970 | +98.0% | 0.03% | +31.8% |
| Q3 2019 | $165,000 | +28.9% | 32,820 | +94.4% | 0.02% | +69.2% |
| Q1 2019 | $128,000 | – | 16,882 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 675,000 | $918,000 | 1.02% |
| Sargent Investment Group, LLC | 1,108,233 | $2,028,000 | 0.63% |
| Skylands Capital, LLC | 2,347,034 | $3,192,000 | 0.52% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 253,000 | $344,000 | 0.37% |
| Avenir Corp | 2,314,854 | $3,148,000 | 0.33% |
| Granahan Investment Management | 1,511,029 | $2,055,000 | 0.07% |
| ACT CAPITAL MANAGEMENT, LLC | 35,000 | $48,000 | 0.07% |
| Winning Points Advisors, LLC | 22,900 | $33,000 | 0.04% |
| Cowen Prime Advisors LLC | 42,200 | $57,000 | 0.03% |
| Seelaus Asset Management LLC | 23,900 | $33,000 | 0.03% |